NTRR Finalizes First Commercial Run of Diamond Anvil Vapor Pen to Capitalize on Cannabis Ancillary Market
TAMPA, Fla.–(BUSINESS WIRE)–
Neutra Corp.(NTRR) finalizes plans for its first commercial production run of the cutting-edgeDiamond Anvil Vapor Pen just as analysts are predicting the cannabis industry will not only be legal, but have more annual revenue than the NFL by 2020.
Greenwave Advisors, a cannabis-focused research and analysis firm, recently projected federal legalization of the herb in the next six years, which would push first-year countrywide revenues to an estimated $35 billion, surpassing the annual revenue of the NFL. Even without full federal legalization, Greenwave still projects $21 billion in legal cannabis revenues, however, the firm believes 12 states and the District of Columbia will have legalized recreational cannabis by 2020, with medical cannabis being available in 37 states. Currently 23 states have legalized medical cannabis and two states have legalized recreational cannabis use.
“This is the kind of research that gets us excited because we are more than ready to deliver new market-ready ancillary products to the fast-growing cannabis sector. The timing is perfect because we’re preparing for the first commercial run of our cutting-edge all-in-one portable Diamond Anvil vaporization pen,” said NTRR CEO Chris Brown.
Earlier this year, NTRR acquired vapor innovators Diamond Anvil Designs in order to develop a lightweight, portable, smoke-free delivery system that will stand out from competing products in the marketplace. The new Diamond Anvil vapor pen features customizable power levels, multi-substance vaporization capacity and best-in-class durability, making it a unique and groundbreaking product in the fast-growing vaporization industry. Neutra Corp. ordered the first production run from the manufacturer in July.
“The demand for cannabis and cannabis-related products is growing every day. The Diamond Anvil Vapor Pen is only one of several game-changing products we have in the pipeline to capitalize on what is proving to be an unprecedented market opportunity.”
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), Growlife Inc. (PHOT) and Medbox Inc. (MDBX), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
